Home » Topics » BioWorld Science

BioWorld Science
RSS

Olpadronate associated with improvement in osteogenesis imperfecta

Nov. 24, 1997

EntreMed: Q3 1997 highlights

Nov. 24, 1997

Accolate now available in Canada

Nov. 21, 1997

Floxin recommended for FDA approval

Nov. 21, 1997

Allergan files registration statement for new company

Nov. 21, 1997

RIGScan EMEA review delayed

Nov. 21, 1997

Amylin, SIDDCO join forces for metabolic drug discovery

Nov. 21, 1997

Imutec licenses novel anticancer compounds from Ion

Nov. 21, 1997

Update on pagoclone

Nov. 21, 1997

InKine (formerly Panax) completes acquisitions, raises funds for CBP-1011 development

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...